Treatment of postmenopausal disorders
CA 2018818 C · Owner: Orion-Yhtyma Oy · Inventors: Hirvonen, Erkki; Gordin, Ariel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method is provided for the treatment of postmenopausal disorders which comprises administering to a woman in single oral, daily dose form during an uninterrupted consecutive sequence of 90 days, (a) a daily, oral dose in an uninterrupted consecutive, sequence for 69 days starting on the first day of a naturally occurring or synthetic estrogenic compound effective in the prevention of climacteric symptoms; (b) a daily, oral dose in an uninterrupted consecutive sequence from the 70th day to the 83rd day following said first day, of a naturally occurring or synthetic estrogenic compound and a compound having progestational activity effective in preventing the development of endometrial …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 12, 1990 and granted January 16, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 12, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 12, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.